Mevrometostat

 

Mevrometostat

https://newdrugapprovals.org/2026/02/10/mevrometostat/

Anthony Melvin Crasto AfricurePharma Row2Tech Anax AdvectProc Niper-G

Fanregratinib

Fanregratinib

https://newdrugapprovals.org/2026/01/23/fanregratinib/

Anthony Melvin Crasto AfricurePharma Row2Tech Anax AdvectProc Niper-G

 

Enrupatinib

  Enrupatinib

https://newdrugapprovals.org/2026/01/20/enrupatinib/

Anthony Melvin Crasto AfricurePharma Row2Tech Anax AdvectProc Niper-G

Talogreptide mesaroxetan

 

Talogreptide mesaroxetan

LINK

https://newdrugapprovals.org/2025/12/10/talogreptide-mesaroxetan/

BEXICASERIN

 

Bexicaserin

https://newdrugapprovals.org/2025/04/15/bexicaserin/

MILVEXIAN

 

MILVEXIAN

https://newdrugapprovals.org/2020/10/24/milvexian/

Cetuximab sarotalocan sodium

 Cetuximab Sarotalocan Sodium (Genetical Recombination)

Cetuximab Sarotalocan Sodium is an antibody-drug-conjugate (molecular weight: 156,000-158,000) consisting of tetrasodium salt of Sarotalocan (6-({[3-({(OC-6-13)-bis({3-[bis(3-sulfopropyl)(3-sulfonatopropyl)azaniumyl]propyl}dimethylsilanolato-κO,κO')[(phtalocyaninato(2-)κN29,κN30,κN31,κN32)-1-yl]silicon}oxy)propoxy]carbonyl}amino)hexanoyl (C70H96N11O24S6Si3; molecular weight: 1,752.22)) attached to an average of 2-3 Lys residues of Cetuximab.

[2166339-33-7 , Cetuximab sarotalocan]

https://newdrugapprovals.org/2020/10/12/cetuximab-sarotalocan-sodium/